 | • レポートコード：20QY06-05520 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗血友病因子薬のグローバル市場について種類別（250 IU、500 IU、1000 IU、1500 IU、2000 IU、3000 IU、4000 IU、その他）、用途別（成人、小児科）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗血友病因子薬市場の概要 ・世界の主要地域別抗血友病因子薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗血友病因子薬市場規模2015-2026：種類別（250 IU、500 IU、1000 IU、1500 IU、2000 IU、3000 IU、4000 IU、その他） ・世界の抗血友病因子薬市場規模2015-2026：用途別（成人、小児科） ・抗血友病因子薬の北米市場規模2015-2020 ・抗血友病因子薬のヨーロッパ市場規模2015-2020 ・抗血友病因子薬の中国市場規模2015-2020 ・抗血友病因子薬の日本市場規模2015-2020 ・抗血友病因子薬の東南アジア市場規模2015-2020 ・抗血友病因子薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bayer、Takeda、Novo Nordisk、Pfizer、Grifols、CSL Behring、Sanofi、Cigna、Octapharma、GC Pharma、Hualan Biological Engineering、Shanghai RAAS blood products） ・抗血友病因子薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗血友病因子薬の市場動向・機会・課題 ・調査の結論 |
Antihemophilic Factor Drug is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding.
Market Analysis and Insights: Global Antihemophilic Factor Drug Market
The global Antihemophilic Factor Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Antihemophilic Factor Drug Scope and Market Size
The global Antihemophilic Factor Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antihemophilic Factor Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antihemophilic Factor Drug market is segmented into
250 IU
500 IU
1000 IU
1500 IU
2000 IU
3000 IU
4000 IU
Other potencies
Segment by Application, the Antihemophilic Factor Drug market is segmented into
Adult
Pediatric
The Antihemophilic Factor Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Antihemophilic Factor Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antihemophilic Factor Drug Market Share Analysis
Antihemophilic Factor Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antihemophilic Factor Drug business, the date to enter into the Antihemophilic Factor Drug market, Antihemophilic Factor Drug product introduction, recent developments, etc.
The major vendors covered:
Bayer
Takeda
Novo Nordisk
Pfizer
Grifols
CSL Behring
Sanofi
Cigna
Octapharma
GC Pharma
Hualan Biological Engineering
Shanghai RAAS blood products
Table of Contents
1 Antihemophilic Factor Drug Market Overview
1.1 Antihemophilic Factor Drug Product Scope
1.2 Antihemophilic Factor Drug Segment by Type
1.2.1 Global Antihemophilic Factor Drug Sales by Type (2020-2026)
1.2.2 250 IU
1.2.3 500 IU
1.2.4 1000 IU
1.2.5 1500 IU
1.2.6 2000 IU
1.2.7 3000 IU
1.2.8 4000 IU
1.2.9 Other potencies
1.3 Antihemophilic Factor Drug Segment by Application
1.3.1 Global Antihemophilic Factor Drug Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Pediatric
1.4 Antihemophilic Factor Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Antihemophilic Factor Drug Sales Growth Rate (2015-2026)
1.4.2 Global Antihemophilic Factor Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Antihemophilic Factor Drug Price Trends (2015-2026)
2 Antihemophilic Factor Drug Estimate and Forecast by Region
2.1 Global Antihemophilic Factor Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Antihemophilic Factor Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Antihemophilic Factor Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Antihemophilic Factor Drug Revenue Market Share by Region (2015-2020)
2.3 Global Antihemophilic Factor Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Antihemophilic Factor Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Antihemophilic Factor Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antihemophilic Factor Drug Estimates and Projections (2015-2026)
2.4.2 Europe Antihemophilic Factor Drug Estimates and Projections (2015-2026)
2.4.3 China Antihemophilic Factor Drug Estimates and Projections (2015-2026)
2.4.4 Japan Antihemophilic Factor Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Antihemophilic Factor Drug Estimates and Projections (2015-2026)
2.4.6 India Antihemophilic Factor Drug Estimates and Projections (2015-2026)
3 Global Antihemophilic Factor Drug Competition Landscape by Players
3.1 Global Top Antihemophilic Factor Drug Players by Sales (2015-2020)
3.2 Global Top Antihemophilic Factor Drug Players by Revenue (2015-2020)
3.3 Global Antihemophilic Factor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihemophilic Factor Drug as of 2019)
3.4 Global Antihemophilic Factor Drug Average Price by Company (2015-2020)
3.5 Manufacturers Antihemophilic Factor Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Antihemophilic Factor Drug Players (Opinion Leaders)
4 Global Antihemophilic Factor Drug Market Size by Type
4.1 Global Antihemophilic Factor Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Antihemophilic Factor Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Antihemophilic Factor Drug Price by Type (2014-2020)
4.2 Global Antihemophilic Factor Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Antihemophilic Factor Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Antihemophilic Factor Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Antihemophilic Factor Drug Price Forecast by Type (2021-2026)
5 Global Antihemophilic Factor Drug Market Size by Application
5.1 Global Antihemophilic Factor Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Antihemophilic Factor Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Antihemophilic Factor Drug Price by Application (2015-2020)
5.2 Global Antihemophilic Factor Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Antihemophilic Factor Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Antihemophilic Factor Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Antihemophilic Factor Drug Price Forecast by Application (2021-2026)
3 North America Antihemophilic Factor Drug Market Facts & Figures
3.2 North America Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
3.3 North America Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
3.4 North America Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
4 Europe Antihemophilic Factor Drug Market Facts & Figures
4.2 Europe Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
4.3 Europe Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
4.4 Europe Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
5 China Antihemophilic Factor Drug Market Facts & Figures
5.2 China Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
5.3 China Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
5.4 China Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
6 Japan Antihemophilic Factor Drug Market Facts & Figures
6.2 Japan Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
6.3 Japan Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
6.4 Japan Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Antihemophilic Factor Drug Market Facts & Figures
7.2 Southeast Asia Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
8 India Antihemophilic Factor Drug Market Facts & Figures
8.2 India Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
8.3 India Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
8.4 India Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Antihemophilic Factor Drug Business
12.1 Bayer
12.1.1 Bayer Antihemophilic Factor Drug Corporation Information
12.1.2 Bayer Antihemophilic Factor Drug Business Overview and Total Revenue
12.1.3 Bayer Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Antihemophilic Factor Drug Products Offered
12.1.5 Bayer Recent Development
12.2 Takeda
12.2.1 Takeda Antihemophilic Factor Drug Corporation Information
12.2.2 Takeda Antihemophilic Factor Drug Business Overview and Total Revenue
12.2.3 Takeda Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Takeda Antihemophilic Factor Drug Products Offered
12.2.5 Takeda Recent Development
12.3 Novo Nordisk
12.3.1 Novo Nordisk Antihemophilic Factor Drug Corporation Information
12.3.2 Novo Nordisk Antihemophilic Factor Drug Business Overview and Total Revenue
12.3.3 Novo Nordisk Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novo Nordisk Antihemophilic Factor Drug Products Offered
12.3.5 Novo Nordisk Recent Development
12.4 Pfizer
12.4.1 Pfizer Antihemophilic Factor Drug Corporation Information
12.4.2 Pfizer Antihemophilic Factor Drug Business Overview and Total Revenue
12.4.3 Pfizer Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Antihemophilic Factor Drug Products Offered
12.4.5 Pfizer Recent Development
12.5 Grifols
12.5.1 Grifols Antihemophilic Factor Drug Corporation Information
12.5.2 Grifols Antihemophilic Factor Drug Business Overview and Total Revenue
12.5.3 Grifols Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Grifols Antihemophilic Factor Drug Products Offered
12.5.5 Grifols Recent Development
12.6 CSL Behring
12.6.1 CSL Behring Antihemophilic Factor Drug Corporation Information
12.6.2 CSL Behring Antihemophilic Factor Drug Business Overview and Total Revenue
12.6.3 CSL Behring Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 CSL Behring Antihemophilic Factor Drug Products Offered
12.6.5 CSL Behring Recent Development
12.7 Sanofi
12.7.1 Sanofi Antihemophilic Factor Drug Corporation Information
12.7.2 Sanofi Antihemophilic Factor Drug Business Overview and Total Revenue
12.7.3 Sanofi Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Antihemophilic Factor Drug Products Offered
12.7.5 Sanofi Recent Development
12.8 Cigna
12.8.1 Cigna Antihemophilic Factor Drug Corporation Information
12.8.2 Cigna Antihemophilic Factor Drug Business Overview and Total Revenue
12.8.3 Cigna Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Cigna Antihemophilic Factor Drug Products Offered
12.8.5 Cigna Recent Development
12.9 Octapharma
12.9.1 Octapharma Antihemophilic Factor Drug Corporation Information
12.9.2 Octapharma Antihemophilic Factor Drug Business Overview and Total Revenue
12.9.3 Octapharma Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Octapharma Antihemophilic Factor Drug Products Offered
12.9.5 Octapharma Recent Development
12.10 GC Pharma
12.10.1 GC Pharma Antihemophilic Factor Drug Corporation Information
12.10.2 GC Pharma Antihemophilic Factor Drug Business Overview and Total Revenue
12.10.3 GC Pharma Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 GC Pharma Antihemophilic Factor Drug Products Offered
12.10.5 GC Pharma Recent Development
12.11 Hualan Biological Engineering
12.11.1 Hualan Biological Engineering Antihemophilic Factor Drug Corporation Information
12.11.2 Hualan Biological Engineering Antihemophilic Factor Drug Business Overview and Total Revenue
12.11.3 Hualan Biological Engineering Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hualan Biological Engineering Antihemophilic Factor Drug Products Offered
12.11.5 Hualan Biological Engineering Recent Development
12.12 Shanghai RAAS blood products
12.12.1 Shanghai RAAS blood products Antihemophilic Factor Drug Corporation Information
12.12.2 Shanghai RAAS blood products Antihemophilic Factor Drug Business Overview and Total Revenue
12.12.3 Shanghai RAAS blood products Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Shanghai RAAS blood products Antihemophilic Factor Drug Products Offered
12.12.5 Shanghai RAAS blood products Recent Development
13 Antihemophilic Factor Drug Manufacturing Cost Analysis
13.1 Antihemophilic Factor Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antihemophilic Factor Drug
13.4 Antihemophilic Factor Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antihemophilic Factor Drug Distributors List
14.3 Antihemophilic Factor Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antihemophilic Factor Drug Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Antihemophilic Factor Drug Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Antihemophilic Factor Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Antihemophilic Factor Drug Sales (K MT) by Region (2015-2020)
Table 5. Global Antihemophilic Factor Drug Sales Market Share by Region (2015-2020)
Table 6. Global Antihemophilic Factor Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Antihemophilic Factor Drug Revenue Share by Region (2015-2020)
Table 8. Global Antihemophilic Factor Drug Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Antihemophilic Factor Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Antihemophilic Factor Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Antihemophilic Factor Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Antihemophilic Factor Drug (K MT) of Key Companies (2015-2020)
Table 13. Global Antihemophilic Factor Drug Sales Share by Company (2015-2020)
Table 14. Global Antihemophilic Factor Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Antihemophilic Factor Drug Revenue Share by Company (2015-2020)
Table 16. Global Antihemophilic Factor Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihemophilic Factor Drug as of 2019)
Table 17. Global Antihemophilic Factor Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Antihemophilic Factor Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Antihemophilic Factor Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Antihemophilic Factor Drug Players
Table 22. Global Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 23. Global Antihemophilic Factor Drug Sales Share by Type (2015-2020)
Table 24. Global Antihemophilic Factor Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Antihemophilic Factor Drug Price (K MT) by Type (2015-2020)
Table 26. Global Antihemophilic Factor Drug Sales Share by Type (2021-2026)
Table 27. Global Antihemophilic Factor Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Antihemophilic Factor Drug Revenue Share by Type (2021-2026)
Table 29. Global Antihemophilic Factor Drug Price (K MT) by Type (2021-2026)
Table 30. Global Antihemophilic Factor Drug Sales (K MT) by Application (2015-2020)
Table 31. Global Antihemophilic Factor Drug Sales Share by Application (2015-2020)
Table 32. Global Antihemophilic Factor Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Antihemophilic Factor Drug Price (K MT) by Application (2015-2020)
Table 34. Global Antihemophilic Factor Drug Sales (K MT) by Application (2021-2026)
Table 35. Global Antihemophilic Factor Drug Sales Share by Application (2021-2026)
Table 36. Global Antihemophilic Factor Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Antihemophilic Factor Drug Revenue Share by Application (2021-2026)
Table 38. Global Antihemophilic Factor Drug Price (K MT) by Application (2021-2026)
Table 39. United States Antihemophilic Factor Drug Sales (K MT) by Company (2015-2020)
Table 40. United States Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
Table 41. United States Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
Table 43. United States Antihemophilic Factor Drug Sales (K MT) by Application (2015-2020)
Table 44. United States Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Antihemophilic Factor Drug Sales (K MT) by Company (2015-2020)
Table 46. Europe Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 48. Europe Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Antihemophilic Factor Drug Sales (K MT) by Application (2015-2020)
Table 50. Europe Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
Table 51. China Antihemophilic Factor Drug Sales (K MT) by Company (2015-2020)
Table 52. China Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
Table 53. China Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 54. China Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
Table 55. China Antihemophilic Factor Drug Sales (K MT) by Application (2015-2020)
Table 56. China Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Antihemophilic Factor Drug Sales (K MT) by Company (2015-2020)
Table 58. Japan Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 60. Japan Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Antihemophilic Factor Drug Sales (K MT) by Application (2015-2020)
Table 62. Japan Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Antihemophilic Factor Drug Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
Table 69. India Antihemophilic Factor Drug Sales (K MT) by Company (2015-2020)
Table 70. India Antihemophilic Factor Drug Sales Market Share by Company (2015-2020)
Table 71. India Antihemophilic Factor Drug Sales (K MT) by Type (2015-2020)
Table 72. India Antihemophilic Factor Drug Sales Market Share by Type (2015-2020)
Table 73. India Antihemophilic Factor Drug Sales (K MT) by Application (2015-2020)
Table 74. India Antihemophilic Factor Drug Sales Market Share by Application (2015-2020)
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer Antihemophilic Factor Drug Product
Table 79. Bayer Recent Development
Table 80. Takeda Corporation Information
Table 81. Takeda Description and Business Overview
Table 82. Takeda Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Takeda Antihemophilic Factor Drug Product
Table 84. Takeda Recent Development
Table 85. Novo Nordisk Corporation Information
Table 86. Novo Nordisk Description and Business Overview
Table 87. Novo Nordisk Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novo Nordisk Antihemophilic Factor Drug Product
Table 89. Novo Nordisk Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer Antihemophilic Factor Drug Product
Table 94. Pfizer Recent Development
Table 95. Grifols Corporation Information
Table 96. Grifols Description and Business Overview
Table 97. Grifols Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Grifols Antihemophilic Factor Drug Product
Table 99. Grifols Recent Development
Table 100. CSL Behring Corporation Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. CSL Behring Antihemophilic Factor Drug Product
Table 104. CSL Behring Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sanofi Antihemophilic Factor Drug Product
Table 109. Sanofi Recent Development
Table 110. Cigna Corporation Information
Table 111. Cigna Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Cigna Description and Business Overview
Table 113. Cigna Antihemophilic Factor Drug Product
Table 114. Cigna Recent Development
Table 115. Octapharma Corporation Information
Table 116. Octapharma Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Octapharma Description and Business Overview
Table 118. Octapharma Antihemophilic Factor Drug Product
Table 119. Octapharma Recent Development
Table 120. GC Pharma Corporation Information
Table 121. GC Pharma Description and Business Overview
Table 122. GC Pharma Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. GC Pharma Antihemophilic Factor Drug Product
Table 124. GC Pharma Recent Development
Table 125. Hualan Biological Engineering Corporation Information
Table 126. Hualan Biological Engineering Description and Business Overview
Table 127. Hualan Biological Engineering Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Hualan Biological Engineering Antihemophilic Factor Drug Product
Table 129. Hualan Biological Engineering Recent Development
Table 130. Shanghai RAAS blood products Corporation Information
Table 131. Shanghai RAAS blood products Description and Business Overview
Table 132. Shanghai RAAS blood products Antihemophilic Factor Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Shanghai RAAS blood products Antihemophilic Factor Drug Product
Table 134. Shanghai RAAS blood products Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Antihemophilic Factor Drug Distributors List
Table 138. Antihemophilic Factor Drug Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Antihemophilic Factor Drug Product Picture
Figure 2. Global Antihemophilic Factor Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antihemophilic Factor Drug Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Pediatric Examples
Figure 8. Global Antihemophilic Factor Drug Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Antihemophilic Factor Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Antihemophilic Factor Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Antihemophilic Factor Drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Antihemophilic Factor Drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Antihemophilic Factor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Antihemophilic Factor Drug Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Antihemophilic Factor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Antihemophilic Factor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Antihemophilic Factor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Antihemophilic Factor Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Antihemophilic Factor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Antihemophilic Factor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Antihemophilic Factor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Antihemophilic Factor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Antihemophilic Factor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Antihemophilic Factor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Antihemophilic Factor Drug Players Market Share by Revenue in Antihemophilic Factor Drug 2015 & 2019
Figure 26. Antihemophilic Factor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Antihemophilic Factor Drug Revenue Share by Type (2015-2020)
Figure 28. Global Antihemophilic Factor Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Antihemophilic Factor Drug Revenue Share by Application (2015-2020)
Figure 30. Global Antihemophilic Factor Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Antihemophilic Factor Drug Sales Market Share by Type in 2019
Figure 32. United States Antihemophilic Factor Drug Sales Market Share by Type in 2019
Figure 33. Europe Antihemophilic Factor Drug Sales Market Share by Company in 2019
Figure 34. Europe Antihemophilic Factor Drug Sales Market Share by Type in 2019
Figure 35. Europe Antihemophilic Factor Drug Sales Market Share by Application in 2019
Figure 36. China Antihemophilic Factor Drug Sales Market Share by Company in 2019
Figure 37. China Antihemophilic Factor Drug Sales Market Share by Type in 2019
Figure 38. China Antihemophilic Factor Drug Sales Market Share by Application in 2019
Figure 39. Japan Antihemophilic Factor Drug Sales Market Share by Company in 2019
Figure 40. Japan Antihemophilic Factor Drug Sales Market Share by Type in 2019
Figure 41. Japan Antihemophilic Factor Drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Antihemophilic Factor Drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Antihemophilic Factor Drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Antihemophilic Factor Drug Sales Market Share by Application in 2019
Figure 45. India Antihemophilic Factor Drug Sales Market Share by Company in 2019
Figure 46. India Antihemophilic Factor Drug Sales Market Share by Type in 2019
Figure 47. India Antihemophilic Factor Drug Sales Market Share by Application in 2019
Figure 48. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Cigna Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. GC Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Hualan Biological Engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Shanghai RAAS blood products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Antihemophilic Factor Drug
Figure 62. Manufacturing Process Analysis of Antihemophilic Factor Drug
Figure 63. Antihemophilic Factor Drug Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
凝固因子IXの世界市場レポート2020 Market Analysis and Insights: Global Coagulation Factor IX Market The global Coagulation Factor IX market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Coagulation Factor IX Scope and Market Size The global Co…- インスリン様成長因子の世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor Market The global Insulin Like Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insulin Like Growth Factor Scope and Market Siz…
- 結合組織成長因子の世界市場レポート2020 Market Analysis and Insights: Global Connective Tissue Growth Factor Market The global Connective Tissue Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Connective Tissue Growth Factor Scope…
- 上皮成長因子（EGF）の世界市場レポート2020 A recently published report by QY Research titled Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also sta…
- 凝固因子濃縮物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Coagulation Factor Concentrate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coagulation Fa…